PMID: 9653097Jul 7, 1998Paper

B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28

The Journal of Experimental Medicine
F FallarinoT F Gajewski

Abstract

Ligation of cytotoxic T lymphocyte antigen 4 (CTLA4) appears to inhibit T cell responses. Four mechanisms have been proposed to explain the inhibitory activity of CTLA4: competition for B7-1 and B7-2 binding by CD28; sequestration of signaling molecules away from CD28 via endocytosis; delivery of a signal that antagonizes a CD28 signal; and delivery of a signal that antagonizes a T cell receptor (TCR) signal. As three of these potential mechanisms involve functional antagonism of CD28, an experimental model was designed to determine whether CTLA4 could inhibit T cell function in the absence of CD28. TCR transgenic/recombinase activating gene 2-deficient/CD28-wild-type or CD28-deficient mice were generated and immunized with an antigen-expressing tumor. Primed T cells from both types of mice produced cytokines and proliferated in response to stimulator cells lacking B7 expression. However, whereas the response of CD28+/+ T cells was augmented by costimulation with B7-1, the response of the CD28-/- T cells was strongly inhibited. This inhibition was reversed by monoclonal antibody against B7-1 or CTLA4. Thus, CTLA4 can potently inhibit T cell activation in the absence of CD28, indicating that antagonism of a TCR-mediated signal i...Continue Reading

References

Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Sep 1, 1994·Immunity·J M GreenC B Thompson
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jan 1, 1995·The Journal of Experimental Medicine·H SchneiderC E Rudd
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Feb 15, 1996·Transplantation·K KawaiP S Ohashi
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jun 1, 1996·The Journal of Experimental Medicine·T L WalunasJ A Bluestone
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Nov 14, 1997·Immunity·C B Thompson, J P Allison
Jan 13, 1998·Immunology Today·Y Liu

❮ Previous
Next ❯

Citations

Jan 19, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Joseph R Podojil, Stephen D Miller
Mar 27, 2001·Transplantation Proceedings·M AlegreJ Bluestone
Apr 21, 1999·Current Opinion in Cell Biology·C A Chambers, J P Allison
Oct 2, 2001·Critical Reviews in Oncology/hematology·P M McLaughlinL F de Leij
Jun 18, 2003·Trends in Immunology·David M SansomYong Zheng
Mar 22, 2002·Nature Reviews. Immunology·M L AlegreC B Thompson
Oct 7, 2004·Nature Immunology·Ciriana OrabonaPaolo Puccetti
Jan 26, 2008·Nature Reviews. Immunology·Christopher E Rudd
Apr 2, 1999·Immunology and Cell Biology·K D McCoy, G Le Gros
Feb 4, 2009·The Journal of Experimental Medicine·Randall H FriedlineCynthia A Chambers
Mar 10, 2001·Cold Spring Harbor Symposia on Quantitative Biology·C A Chambers, J P Allison
Apr 15, 2004·Molecular and Cellular Biology·Erika ScharschmidtDaniel Krappmann
Oct 18, 2005·Molecular and Cellular Biology·Richard V ParryJames L Riley
Mar 23, 2006·Annual Review of Immunology·Wendy A TeftJoaquín Madrenas
May 15, 2001·American Journal of Respiratory Cell and Molecular Biology·J S BurrJ M Green
May 12, 2007·The Review of Diabetic Studies : RDS·Bernhard O Boehm, Jeffrey A Bluestone
Sep 4, 2013·Clinical & Developmental Immunology·Nien Yee Kow, Anselm Mak
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·C A ChambersJ P Allison
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·F LuhderD Mathis
Sep 22, 2005·Current Rheumatology Reports·Sarah L MackiePaul Emery
Jul 16, 2009·Cellular and Molecular Life Sciences : CMLS·Gusheng TangQian Shen
Jun 27, 2009·Immunopharmacology and Immunotoxicology·Yu-Jen ChenYu-Yawn Chen
Aug 6, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Yu-Chuen HuangYu-Jen Chen
Mar 26, 2005·Immunological Reviews·Stephen C L GoughDavid M Sansom
Sep 6, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D T DeurlooA J M van Oosterhout
Jan 15, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D T Deurloo, A J M van Oosterhout
Jun 23, 2015·Immunology Letters·Maria Teresa P de AquinoAnil Shanker
Jan 10, 2006·International Immunopharmacology·Jie-Jen LeeYu-Jen Chen
Apr 11, 2015·Cancer Cell·Suzanne L TopalianDrew M Pardoll
Mar 10, 2001·Immunity·R J GreenwaldA H Sharpe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.